SMARCA4型
医学
罕见病
小细胞癌
SMARCB1型
突变
卵巢
化疗
疾病
病理
体细胞
卵巢癌
造血干细胞移植
癌症研究
肿瘤科
作者
M.F. Simões,Alexandre André Balieiro Anastácio da Costa,Tullio Novaes Silva,Lizieux Fernandes,Graziele Bovolim,Giovana Tardin Torrezan,Dirce Maria Carraro,Glauco Baiocchi,Ademir Narcizo Oliveira Menezes,Elizabeth Santana Dos Santos,Louise De Brot
标识
DOI:10.3390/curroncol29020037
摘要
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive condition that is associated with the SMARCA4 mutation and has a dismal prognosis. It is generally diagnosed in young women. Here, we report a case of a young woman with SCCOHT harboring a rare molecular finding with a highly aggressive biological behavior. The patient had a somatic SMARCB1 mutation instead of an expected SMARCA4 alteration. Even though the patient was treated with high-dose chemotherapy followed by stem cell transplantation, she evolved with disease progression and died 11 months after her first symptoms appeared. We present a literature review of this rare disease and discuss the findings in the present patient in comparison to expected molecular alterations and options for SCCOHT treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI